Tomohisa Baba

3.3k total citations
185 papers, 2.2k citations indexed

About

Tomohisa Baba is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Tomohisa Baba has authored 185 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Pulmonary and Respiratory Medicine, 43 papers in Epidemiology and 35 papers in Physiology. Recurrent topics in Tomohisa Baba's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (120 papers), Lung Cancer Treatments and Mutations (36 papers) and Sarcoidosis and Beryllium Toxicity Research (25 papers). Tomohisa Baba is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (120 papers), Lung Cancer Treatments and Mutations (36 papers) and Sarcoidosis and Beryllium Toxicity Research (25 papers). Tomohisa Baba collaborates with scholars based in Japan, United States and Australia. Tomohisa Baba's co-authors include Takashi Ogura, Tae Iwasawa, Eri Hagiwara, Tamiko Takemura, Hideya Kitamura, Koji Okudela, Akimasa Sekine, Terufumi Kato, Satoshi Ikeda and Takashi Ogura and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Tomohisa Baba

172 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomohisa Baba Japan	26	1.7k	592	389	313	228	185	2.2k
Stefania Cerri Italy	29	1.4k 0.8×	559 0.9×	504 1.3×	133 0.4×	327 1.4×	95	2.3k
Dai Hashimoto Japan	24	1.5k 0.9×	692 1.2×	580 1.5×	82 0.3×	240 1.1×	86	2.2k
Koichiro Nakata Japan	17	1.3k 0.8×	396 0.7×	304 0.8×	159 0.5×	93 0.4×	57	1.6k
Hidenori Ichiyasu Japan	19	805 0.5×	246 0.4×	319 0.8×	175 0.6×	69 0.3×	80	1.4k
Biman Saikia India	18	632 0.4×	549 0.9×	263 0.7×	61 0.2×	110 0.5×	87	1.4k
Masaki Tominaga Japan	17	636 0.4×	193 0.3×	179 0.5×	110 0.4×	53 0.2×	68	1.1k
Michael Girschikofsky Austria	15	231 0.1×	645 1.1×	223 0.6×	332 1.1×	231 1.0×	33	2.1k
C Mayaud France	27	552 0.3×	131 0.2×	854 2.2×	444 1.4×	170 0.7×	79	2.1k
David Boutboul France	26	265 0.2×	213 0.4×	316 0.8×	532 1.7×	331 1.5×	91	2.2k
Louis E. Siltzbach United States	23	1.0k 0.6×	1.6k 2.7×	415 1.1×	223 0.7×	122 0.5×	59	2.4k

Countries citing papers authored by Tomohisa Baba

Since Specialization

Citations

This map shows the geographic impact of Tomohisa Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohisa Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohisa Baba more than expected).

Fields of papers citing papers by Tomohisa Baba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohisa Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohisa Baba. The network helps show where Tomohisa Baba may publish in the future.

Co-authorship network of co-authors of Tomohisa Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohisa Baba. A scholar is included among the top collaborators of Tomohisa Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohisa Baba. Tomohisa Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abe, Shinji, Arata Azuma, Yoshinobu Saito, et al.. (2024). Direct hemoperfusion with polymyxin B immobilized fiber column (PMX) treatment for acute exacerbation of idiopathic pulmonary fibrosis: A prospective multicenter cohort study. Respiratory Investigation. 63(1). 102–108.

Isobe, Kazutoshi, Yasuhiko Nakamura, Susumu Sakamoto, et al.. (2024). Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia. ERJ Open Research. 10(2). 981–2023. 4 indexed citations

Sekine, Akimasa, et al.. (2024). Spontaneous regression of acute fibrinous organizing pneumonia induced by COVID-19 vaccination: A case report. Respiratory Investigation. 62(3). 356–359.

Fujimoto, Kazushi, Akimasa Sekine, Eri Hagiwara, et al.. (2024). Favorable treatment response of bevacizumab-combined chemotherapy for advanced or recurrent invasive mucinous adenocarcinoma of the lung: A retrospective observational study. Respiratory Investigation. 62(3). 360–364. 1 indexed citations

Iwasawa, Tae, Toshihiro Misumi, Koji Okudela, et al.. (2024). Correlation of CT-based radiomics analysis with pathological cellular infiltration in fibrosing interstitial lung diseases. Japanese Journal of Radiology. 42(10). 1157–1167. 4 indexed citations

Iwasawa, Tae, Tomohisa Baba, Toshihiro Misumi, et al.. (2024). Evaluation of Progressive Architectural Distortion in Idiopathic Pulmonary Fibrosis Using Deformable Registration of Sequential CT Images. Diagnostics. 14(15). 1650–1650.

Nagasawa, Ryo, Takashi Niwa, Eri Hagiwara, et al.. (2023). Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19. Internal Medicine. 62(21). 3125–3130. 2 indexed citations

Shirai, Tsuyoshi, Yoshinori Tanino, Takefumi Nikaido, et al.. (2023). Utility of budgerigar/pigeon/parrot-specific IgG antibody with ImmunoCAP® in bird-related hypersensitivity pneumonitis caused by other bird species and duvet. Respiratory Investigation. 61(4). 520–526. 4 indexed citations

Iwasawa, Tae, et al.. (2023). Quantitative Analysis for Lung Disease on Thin-Section CT. Diagnostics. 13(18). 2988–2988. 5 indexed citations

10.

Kitamura, Hideya, Tomohisa Baba, Akimasa Sekine, et al.. (2023). Concordance between transbronchial lung cryobiopsy and surgical lung biopsy in patients with idiopathic multicentric Castleman disease: A report of four cases. Respiratory Investigation. 62(1). 1–8.

11.

Sekine, Akimasa, Eri Hagiwara, Satoshi Ikeda, et al.. (2023). Successful tepotinib treatment of adenocarcinoma with MET exon 14 skipping and discordant results between Oncomine Dx target test and ArcherMET: A case report. Molecular and Clinical Oncology. 18(6). 49–49. 2 indexed citations

12.

Baba, Tomohisa, Masahiko Kusumoto, Terufumi Kato, et al.. (2023). Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan. International Journal of Clinical Oncology. 28(12). 1585–1596. 9 indexed citations

13.

Iwasawa, Tae, Tsuneo Yamashiro, Daisuke Utsunomiya, et al.. (2022). Effects of Automatic Deep-Learning-Based Lung Analysis on Quantification of Interstitial Lung Disease: Correlation with Pulmonary Function Test Results and Prognosis. Diagnostics. 12(12). 3038–3038. 13 indexed citations

14.

Yamakawa, Hideaki, Yuko Toyoda, Tomohisa Baba, et al.. (2022). Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review. Journal of Clinical Medicine. 11(13). 3835–3835. 13 indexed citations

15.

Ikeda, Satoshi, Terufumi Kato, Hirotsugu Kenmotsu, et al.. (2021). Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia. Cancers. 13(16). 3979–3979. 15 indexed citations

16.

Saito, Yoshinobu, Shinichi Sasaki, Junya Tominaga, et al.. (2020). Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non–small cell lung cancer. Cancer Science. 112(4). 1495–1505. 10 indexed citations

17.

Sata, Masafumi, Shinichi Sasaki, Yoshinobu Saito, et al.. (2020). Treatment and relapse of interstitial lung disease in nivolumab‐treated patients with non–small cell lung cancer. Cancer Science. 112(4). 1506–1513. 9 indexed citations

18.

Trapnell, Bruce C., Yoshikazu Inoue, Francesco Bonella, et al.. (2020). Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis. New England Journal of Medicine. 383(17). 1635–1644. 59 indexed citations

19.

Nakagawa, Hiroaki, Tomohisa Baba, Shigeru Komatsu, et al.. (2020). Relationship of flow-volume curve pattern on pulmonary function test with clinical and radiological features in idiopathic pulmonary fibrosis. BMC Pulmonary Medicine. 20(1). 1 indexed citations

20.

Iwasawa, Tae, Koji Okudela, Tamiko Takemura, et al.. (2019). Computer-aided Quantification of Pulmonary Fibrosis in Patients with Lung Cancer: Relationship to Disease-free Survival. Radiology. 292(2). 489–498. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact